265 related articles for article (PubMed ID: 16434963)
1. Thyroid hormone receptors mutated in liver cancer function as distorted antimorphs.
Chan IH; Privalsky ML
Oncogene; 2006 Jun; 25(25):3576-88. PubMed ID: 16434963
[TBL] [Abstract][Full Text] [Related]
2. Impaired interaction of mutant thyroid hormone receptors associated with human hepatocellular carcinoma with transcriptional coregulators.
Lin KH; Wu YH; Chen SL
Endocrinology; 2001 Feb; 142(2):653-62. PubMed ID: 11159836
[TBL] [Abstract][Full Text] [Related]
3. Identification of naturally occurring dominant negative mutants of thyroid hormone alpha 1 and beta 1 receptors in a human hepatocellular carcinoma cell line.
Lin KH; Zhu XG; Shieh HY; Hsu HC; Chen ST; McPhie P; Cheng SY
Endocrinology; 1996 Oct; 137(10):4073-81. PubMed ID: 8828459
[TBL] [Abstract][Full Text] [Related]
4. Dominant negative activity of mutant thyroid hormone alpha1 receptors from patients with hepatocellular carcinoma.
Lin KH; Zhu XG; Hsu HC; Chen SL; Shieh HY; Chen ST; McPhie P; Cheng SY
Endocrinology; 1997 Dec; 138(12):5308-15. PubMed ID: 9389515
[TBL] [Abstract][Full Text] [Related]
5. Mutant thyroid hormone receptors (TRs) isolated from distinct cancer types display distinct target gene specificities: a unique regulatory repertoire associated with two renal clear cell carcinomas.
Rosen MD; Chan IH; Privalsky ML
Mol Endocrinol; 2011 Aug; 25(8):1311-25. PubMed ID: 21622534
[TBL] [Abstract][Full Text] [Related]
6. Thyroid hormone receptor mutants implicated in human hepatocellular carcinoma display an altered target gene repertoire.
Chan IH; Privalsky ML
Oncogene; 2009 Nov; 28(47):4162-74. PubMed ID: 19749797
[TBL] [Abstract][Full Text] [Related]
7. Thyroid hormone receptors suppress pituitary tumor transforming gene 1 activity in hepatoma.
Chen RN; Huang YH; Yeh CT; Liao CH; Lin KH
Cancer Res; 2008 Mar; 68(6):1697-706. PubMed ID: 18339849
[TBL] [Abstract][Full Text] [Related]
8. Dominant negative transcriptional regulation by a mutant thyroid hormone receptor-beta in a family with generalized resistance to thyroid hormone.
Sakurai A; Miyamoto T; Refetoff S; DeGroot LJ
Mol Endocrinol; 1990 Dec; 4(12):1988-94. PubMed ID: 2082193
[TBL] [Abstract][Full Text] [Related]
9. Pathological Interactions Between Mutant Thyroid Hormone Receptors and Corepressors and Their Modulation by a Thyroid Hormone Analogue with Therapeutic Potential.
Harrus D; Déméné H; Vasquez E; Boulahtouf A; Germain P; Figueira AC; Privalsky ML; Bourguet W; le Maire A
Thyroid; 2018 Dec; 28(12):1708-1722. PubMed ID: 30235988
[TBL] [Abstract][Full Text] [Related]
10. Defective release of corepressor by hinge mutants of the thyroid hormone receptor found in patients with resistance to thyroid hormone.
Safer JD; Cohen RN; Hollenberg AN; Wondisford FE
J Biol Chem; 1998 Nov; 273(46):30175-82. PubMed ID: 9804773
[TBL] [Abstract][Full Text] [Related]
11. Nuclear corepressors enhance the dominant negative activity of mutant receptors that cause resistance to thyroid hormone.
Tagami T; Jameson JL
Endocrinology; 1998 Feb; 139(2):640-50. PubMed ID: 9449636
[TBL] [Abstract][Full Text] [Related]
12. Expression of mutant thyroid hormone nuclear receptors in human hepatocellular carcinoma cells.
Lin KH; Shieh HY; Chen SL; Hsu HC
Mol Carcinog; 1999 Sep; 26(1):53-61. PubMed ID: 10487522
[TBL] [Abstract][Full Text] [Related]
13. Dominant negative inhibition by mutant thyroid hormone receptors is thyroid hormone response element and receptor isoform specific.
Zavacki AM; Harney JW; Brent GA; Larsen PR
Mol Endocrinol; 1993 Oct; 7(10):1319-30. PubMed ID: 8264663
[TBL] [Abstract][Full Text] [Related]
14. Thyroid hormone resistance syndrome manifests as an aberrant interaction between mutant T3 receptors and transcriptional corepressors.
Yoh SM; Chatterjee VK; Privalsky ML
Mol Endocrinol; 1997 Apr; 11(4):470-80. PubMed ID: 9092799
[TBL] [Abstract][Full Text] [Related]
15. Lack of coactivator interaction can be a mechanism for dominant negative activity by mutant thyroid hormone receptors.
Liu Y; Takeshita A; Misiti S; Chin WW; Yen PM
Endocrinology; 1998 Oct; 139(10):4197-204. PubMed ID: 9751500
[TBL] [Abstract][Full Text] [Related]
16. Differences between the silencing-related properties of the extreme carboxyl-terminal regions of thyroid hormone receptors alpha 1 and beta 1.
Nishiyama K; Matsushita A; Natsume H; Mikami T; Genma R; Sasaki S; Nakamura H
J Endocrinol; 2000 Nov; 167(2):219-27. PubMed ID: 11054635
[TBL] [Abstract][Full Text] [Related]
17. A conserved lysine in the thyroid hormone receptor-alpha1 DNA-binding domain, mutated in hepatocellular carcinoma, serves as a sensor for transcriptional regulation.
Chan IH; Privalsky ML
Mol Cancer Res; 2010 Jan; 8(1):15-23. PubMed ID: 20053725
[TBL] [Abstract][Full Text] [Related]
18. A novel natural mutation in the thyroid hormone receptor defines a dual functional domain that exchanges nuclear receptor corepressors and coactivators.
Tagami T; Gu WX; Peairs PT; West BL; Jameson JL
Mol Endocrinol; 1998 Dec; 12(12):1888-902. PubMed ID: 9849963
[TBL] [Abstract][Full Text] [Related]
19. N-terminal variants of thyroid hormone receptor beta: differential function and potential contribution to syndrome of resistance to thyroid hormone.
Ng L; Forrest D; Haugen BR; Wood WM; Curran T
Mol Endocrinol; 1995 Sep; 9(9):1202-13. PubMed ID: 7491112
[TBL] [Abstract][Full Text] [Related]
20. Direct regulation of androgen receptor-associated protein 70 by thyroid hormone and its receptors.
Tai PJ; Huang YH; Shih CH; Chen RN; Chen CD; Chen WJ; Wang CS; Lin KH
Endocrinology; 2007 Jul; 148(7):3485-95. PubMed ID: 17412801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
